SCHEMBL16618146

SCHEMBL16618146

CCOP(=O)(CCN(CCCC(=O)OC)CCn1cnc2c(O)ncnc21)OCC

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15532441 0.95 HPRT1 (0.51) HPRT1
SCHEMBL15532359 0.90 HPRT1 (0.58) HPRT1
SCHEMBL15531879 0.90 HPRT1 (0.47) HPRT1
SCHEMBL15532426 0.89 HPRT1 (0.73) HPRT1
SCHEMBL15532161 0.86 HPRT1 (0.53) HPRT1
SCHEMBL16618127 0.86 HPRT1 (0.50) HPRT1
SCHEMBL16625398 0.86 HPRT1 (0.80) HPRT1
SCHEMBL16617827 0.85 HPRT1 (0.51) HPRT1
SCHEMBL16617658 0.84 HPRT1 (0.59) HPRT1
SCHEMBL15532393 0.83 HPRT1 (0.65) HPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2847201-B1 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS UNIV QUEENSLAND (AU) 2017-08-16 EP disclosed
US-9200020-B2 6-oxopurine phosphoribosyltransferase inhibitors THE UNIVERSITY OF QUEENSLAND (AU) 2015-12-01 US disclosed
US-20150099722-A1 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS THE UNIVERSITY OF QUEENSLAND (AU) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099722-A1 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS HPRT1, APRT, TPMT HPRT1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.